Surveillance of antimicrobial susceptibility of aerobic and facultative Gram-negative bacilli isolated from patients with intra-abdominal infections in China: The 2002-2009 Study for Monitoring Antimicrobial Resistance Trends (SMART)

International Journal of Antimicrobial Agents

Volumn 36, Issue 6, 2010, Pages 507-512

  Yang, Qiwen ^a   Wang, Hui ^a   Chen, Minjun ^a   Ni, Yuxing ^b   Yu, Yunsong ^c   Hu, Bijie ^d   Sun, Ziyong ^e   Huang, Wenxiang ^f   Hu, Yunjian ^g   Ye, Huifen ^h   Badal, Robert E ⁱ   Xu, Yingchun ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c ZHEJIANG UNIVERSITY   (China)

^d ZHONGSHAN HOSPITAL OF FUDAN UNIVERSITY   (China)

^e HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^f THE FIRST AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

^g BEIJING HOSPITAL   (China)

^h GUANGZHOU FIRST PEOPLE'S HOSPITAL   (China)

ⁱ International Health Management Associates   (United States)

Author keywords

Antimicrobial resistance; Carbapenems; Extended spectrum lactamases; Intra abdominal infections

Indexed keywords

AMIKACIN; CARBAPENEM DERIVATIVE; CEFEPIME; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; ERTAPENEM; EXTENDED SPECTRUM BETA LACTAMASE; IMIPENEM; LEVOFLOXACIN; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULTAMICILLIN; TOBRAMYCIN;

ABDOMINAL INFECTION; AEROBIC BACTERIUM; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; BACTERIUM ISOLATION; BROTH DILUTION; CHINA; CITROBACTER FREUNDII; CONTROLLED STUDY; DRUG SURVEILLANCE PROGRAM; ENTEROBACTER CLOACAE; ENTEROBACTERIACEAE; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; GRAM NEGATIVE INFECTION; KLEBSIELLA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; TREND STUDY;

ANTI-BACTERIAL AGENTS; CHINA; DRUG RESISTANCE, BACTERIAL; GRAM-NEGATIVE BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; MICROBIAL SENSITIVITY TESTS; PERITONITIS;

EID: 78249245418     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2010.09.001     Document Type: Article

References (23)

1. Rossi F., Baquero F., Hsueh P.R., Paterson D.L., Bochicchio G.V., Snyder T.A., et al. In vitro susceptibilities of aerobic and facultatively anaerobic Gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: 2004 results from SMART (Study for Monitoring Antimicrobial Resistance Trends). J Antimicrob Chemother 2006, 58:205-210.
2. Baquero F., Hsueh P.R., Paterson D.L., Rossi F., Bochicchio G.V., Gallagher G., et al. In vitro susceptibilities of aerobic and facultatively anaerobic Gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: 2005 results from Study for Monitoring Antimicrobial Resistance Trends (SMART). Surg Infect (Larchmt) 2009, 10:99-104.
3. Ko W.C., Hsueh P.R. Increasing extended-spectrum β-lactamase production and quinolone resistance among Gram-negative bacilli causing intra-abdominal infections in the Asia/Pacific region: data from the SMART study 2002-2006. J Infect 2009, 59:95-103.
4. Hawser S.P., Bouchillon S.K., Hoban D.J., Badal R.E. In vitro susceptibilities of aerobic and facultative anaerobic Gram-negative bacilli from patients with intra-abdominal infections worldwide from 2005-2007: results from the SMART study. Int J Antimicrob Agents 2009, 34:585-588.
5. Hawser S.P., Bouchillon S.K., Hoban D.J., Badal R.E., Hsueh P.R., Paterson D.L. Emergence of high levels of extended-spectrum β-lactamase-producing Gram-negative bacilli in the Asia-Pacific region: data from the Study for Monitoring Antimicrobial Resistance Trends (SMART) Program, 2007. Antimicrob Agents Chemother 2009, 53:3280-3284.
6. Hoban D.J., Bouchillon S.K., Hawser S.P., Badal R.E. Trends in the frequency of multiple drug-resistant Enterobacteriaceae and their susceptibility to ertapenem, imipenem, and other antimicrobial agents: data from the Study for Monitoring Antimicrobial Resistance Trends 2002 to 2007. Diagn Microbiol Infect Dis 2010, 66:78-86.
7. Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard. 8th ed. Document M7-A8. Wayne, PA: CLSI; 2009.
8. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Twentieth informational supplement. Document M100-S20. Wayne, PA: CLSI; 2010.
9. Guembe M., Cercenado E., Alcalá L., Marín M., Insa R., Bouza E. Evolution of antimicrobial susceptibility patterns of aerobic and facultative Gram-negative bacilli causing intra-abdominal infections: results from the SMART studies 2003-2007. Rev Esp Quimioter 2008, 21:166-173.
10. Nicoletti G., Nicolosi D., Rossolini G.M., Stefani S. Intra-abdominal infections: etiology, epidemiology, microbiological diagnosis and antibiotic resistance. J Chemother 2009, 21(Suppl. 1):5-11.
11. Livermore D.M., Oakton K.J., Carter M.W., Warner M. Activity of ertapenem (MK-0826) versus Enterobacteriaceae with potent β-lactamases. Antimicrob Agents Chemother 2001, 45:2831-2837.
12. Essack S.Y. Treatment options for extended-spectrum β-lactamase-producers. FEMS Microbiol Lett 2000, 190:181-184.
13. Paterson D.L. Recommendations for treatment of severe infections caused by Enterobacteriaceae producing extended-spectrum β-lactamases (ESBLs). Clin Microbiol Infect 2000, 6:460-463.
14. ACT-1 β-lactamase production, porin OmpK35/36 insertional inactivation, and down-regulation of the phosphate transport porin PhoE. Antimicrob Agents Chemother 2006, 50:3396-3406.
15. Bratu S., Landman D., Haag R., Recco R., Eramo A., Alam M., et al. Rapid spread of carbapenem-resistant Klebsiella pneumoniae in New York City: a new threat to our antibiotic armamentarium. Arch Intern Med 2005, 165:1430-1435.
16. Vatopoulos A. High rates of metallo-β-lactamase-producing Klebsiella pneumoniae in Greece-a review of the current evidence. Euro Surveill 2008, 13:1-3.
17. Maltezou H.C., Giakkoupi P., Maragos A., Bolikas M., Raftopoulos V., Papahatzaki H., et al. Outbreak of infections due to KPC-2-producing Klebsiella pneumoniae in a hospital in Crete (Greece). J Infect 2009, 58:213-219.
18. Chanawong A., M'Zali F.H., Heritage J., Xiong J., Hawkey P.M. Three cefotaximases, CTX-M-9 CTX-M-13, and CTX-M-14, among Enterobacteriaceae in the People's Republic of China. Antimicrob Agents Chemother 2002, 46:630-637.
19. Wang H., Kelkar S., Wu W., Chen M., Quinn J.P. Clinical isolates of Enterobacteriaceae producing extended-spectrum β-lactamases: prevalence of CTX-M-3 at a hospital in China. Antimicrob Agents Chemother 2003, 47:790-793.
20. Yang Q.W., Chen M.J., Xu Y.C., Wang H., Sun H.L., Xie X.L. In vitro activity of cefminox and comparators against Escherichia coli, Klebsiella and Bacteroides species. Chin J Laboratory Med 2009, 32:1108-1113.
21. Wang H., Dzink-Fox J.L., Chen M., Levy S.B. Genetic characterization of highly fluoroquinolone-resistant clinical Escherichia coli strains from China: role of acrR mutations. Antimicrob Agents Chemother 2001, 45:1515-1521.
22. Ben-Ami R., Rodríguez-Baño J., Arslan H., Pitout J.D., Quentin C., Calbo E.S., et al. A multinational survey of risk factors for infection with extended-spectrum β-lactamase-producing Enterobacteriaceae in nonhospitalized patients. Clin Infect Dis 2009, 49:682-690.
23. European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. Version 1.1, April 2010. EUCAST; 2010. [accessed 13 September 2010]. http://www.eucast.org/clinical_breakpoints/.